Human Psychopharmacology of Salvinorin A

Single‑group, triple‑masked, Phase I study in healthy volunteers assessing the subjective and behavioural effects of salvinorin A in an initial dose‑ranging protocol.

Participants must have prior inhalation use of Salvia/salvinorin A; sessions involve single inhaled administrations with dose escalation guided by safety assessments.

Outcomes focus on acute subjective effects, behavioural measures, and safety/tolerability through physiological monitoring and laboratory tests.